Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2044261549;61550;61551 chr2:178590401;178590400;178590399chr2:179455128;179455127;179455126
N2AB1880156626;56627;56628 chr2:178590401;178590400;178590399chr2:179455128;179455127;179455126
N2A1787453845;53846;53847 chr2:178590401;178590400;178590399chr2:179455128;179455127;179455126
N2B1137734354;34355;34356 chr2:178590401;178590400;178590399chr2:179455128;179455127;179455126
Novex-11150234729;34730;34731 chr2:178590401;178590400;178590399chr2:179455128;179455127;179455126
Novex-21156934930;34931;34932 chr2:178590401;178590400;178590399chr2:179455128;179455127;179455126
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Fn3-36
  • Domain position: 72
  • Structural Position: 103
  • Q(SASA): 0.3359
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/Q rs751412533 None 0.999 N 0.563 0.316 0.475112344478 gnomAD-3.1.2 6.58E-06 None None None None N None 0 0 0 0 1.93874E-04 None 0 0 0 0 0
E/Q rs751412533 None 0.999 N 0.563 0.316 0.475112344478 gnomAD-4.0.0 6.57082E-06 None None None None N None 0 0 None 0 1.94326E-04 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2557 likely_benign 0.2137 benign -0.921 Destabilizing 0.4 N 0.301 neutral D 0.523311405 None None N
E/C 0.8964 likely_pathogenic 0.8803 pathogenic -0.478 Destabilizing 1.0 D 0.781 deleterious None None None None N
E/D 0.2477 likely_benign 0.248 benign -0.859 Destabilizing 0.99 D 0.483 neutral N 0.518654947 None None N
E/F 0.8833 likely_pathogenic 0.8543 pathogenic -0.167 Destabilizing 0.999 D 0.792 deleterious None None None None N
E/G 0.4155 ambiguous 0.3264 benign -1.288 Destabilizing 0.98 D 0.641 neutral N 0.484032218 None None N
E/H 0.6519 likely_pathogenic 0.6061 pathogenic -0.324 Destabilizing 1.0 D 0.601 neutral None None None None N
E/I 0.4556 ambiguous 0.4283 ambiguous 0.086 Stabilizing 0.996 D 0.765 deleterious None None None None N
E/K 0.3096 likely_benign 0.2301 benign -0.442 Destabilizing 0.99 D 0.504 neutral N 0.511419543 None None N
E/L 0.5947 likely_pathogenic 0.5494 ambiguous 0.086 Stabilizing 0.985 D 0.686 prob.neutral None None None None N
E/M 0.6188 likely_pathogenic 0.5793 pathogenic 0.452 Stabilizing 1.0 D 0.773 deleterious None None None None N
E/N 0.4187 ambiguous 0.4076 ambiguous -1.025 Destabilizing 0.998 D 0.573 neutral None None None None N
E/P 0.7065 likely_pathogenic 0.6284 pathogenic -0.229 Destabilizing 0.998 D 0.74 deleterious None None None None N
E/Q 0.2154 likely_benign 0.19 benign -0.881 Destabilizing 0.999 D 0.563 neutral N 0.5113049 None None N
E/R 0.476 ambiguous 0.3714 ambiguous -0.114 Destabilizing 0.998 D 0.589 neutral None None None None N
E/S 0.3287 likely_benign 0.299 benign -1.33 Destabilizing 0.971 D 0.515 neutral None None None None N
E/T 0.2746 likely_benign 0.2522 benign -1.015 Destabilizing 0.469 N 0.287 neutral None None None None N
E/V 0.2924 likely_benign 0.2661 benign -0.229 Destabilizing 0.98 D 0.67 neutral N 0.470131471 None None N
E/W 0.9604 likely_pathogenic 0.9437 pathogenic 0.186 Stabilizing 1.0 D 0.769 deleterious None None None None N
E/Y 0.7944 likely_pathogenic 0.7565 pathogenic 0.119 Stabilizing 0.999 D 0.787 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.